Association of HLA alleles with the responsiveness to hepatitis B virus vaccination in Korean infants

Vaccine

Volumn 32, Issue 43, 2014, Pages 5638-5644

  Yoon, Jong Hyun ^a,b,c   Shin, Sue ^a,b,c   In, Ji won ^b   Chang, Ju Young ^a   Song, Eun Young ^b   Roh, Eun Youn ^a,b,c  

^a Seoul National University Boramae Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul Metropolitan Public Cord Blood Bank   (South Korea)

Author keywords

HBV vaccination; HLA; Korean; Non responsiveness

Indexed keywords

ANTIBODY; HLA DRB1 ANTIGEN; RECOMBINANT HEPATITIS B VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; HLA A ANTIGEN;

ALLELE; ANTIBODY TITER; ARTICLE; DNA POLYMORPHISM; DOSE RESPONSE; FEMALE; GENE LOCUS; HEPATITIS B; HEPATITIS B VIRUS; HLA SYSTEM; HLA TYPING; HUMAN; INFANCY; INFANT; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; STRATIFICATION; VACCINATION; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; GENE FREQUENCY; GENETICS; GENOTYPE; IMMUNOLOGY; SOUTH KOREA;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HLA-A ANTIGENS; HLA-DRB1 CHAINS; HUMANS; INFANT; MALE; REPUBLIC OF KOREA;

EID: 84908394959     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.08.007     Document Type: Article

References (37)

1. But D.Y., Lai C.L., Yuen M.F. Natural history of hepatitis-related hepatocellular carcinoma. World J Gastroenterol 2008, 14(11):1652-1656.
2. Lok A.S., McMahon B.J. Chronic hepatitis B. Hepatology 2007, 45(2):507-539.
3. Koff R.S. Review article: vaccination and viral hepatitis-current status and future prospects. Aliment Pharmacol Ther 2007, 26(10):1285-1292.
4. Lee H.S., Han C.J., Kim C.Y. Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis B-endemic area. Cancer 1993, 72(9):2564-2567.
5. Chae H.B., Kim J.H., Kim J.K., Yim H.J. Current status of liver diseases in Korea: hepatitis B. Korean J Hepatol 2009, 15(Suppl 6):S13-S24.
6. Lee H.J. Immunization schedule recommended by Korean pediatric society, 2008. Korean J Pediatr Infect Dis 2008, 15:4.
7. Averhoff F., Mahoney F., Coleman P., Schatz G., Hurwitz E., Margolis H. Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med 1998, 15(1):1-8.
8. Choe B.H. Hepatitis B vaccine prevention of perinatal infection and management of nonresponder. Korean J Pediatr Gastroenterol Nutr 2007, 10(suppl 1):91-100.
9. Bruguera M., Cremades M., Salinas R., Costa J., Grau M., Sans J. Impaired response to recombinant hepatitis B vaccine in HIV-infected persons. J Clin Gastroenterol 1992, 14(1):27-30.
10. Fleming S.J., Moran D.M., Cooksley W.G., Faoagali J.L. Poor response to a recombinant hepatitis B vaccine in dialysis patients. J Infect 1991, 22(3):251-257.
11. Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Shane Pankratz V., Jacobsen S.J. Poland GA: Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination. Vaccine 2004, 22(15-16):1914-1920.
12. Poland G.A., Ovsyannikova I.G., Jacobson R.M. Immunogenetics of seasonal influenza vaccine response. Vaccine 2008, 26(Suppl 4):D35-D40.
13. Egea E., Iglesias A., Salazar M., Morimoto C., Kruskall M.S., Awdeh Z., Schlossman S.F., Alper C.A., Yunis E.J. The cellular basis for lack of antibody response to hepatitis B vaccine in humans. J Exp Med 1991, 173(3):531-538.
14. Kruskall M.S., Alper C.A., Awdeh Z., Yunis E.J., Marcus-Bagley D. The immune response to hepatitis B vaccine in humans: inheritance patterns in families. J Exp Med 1992, 175(2):495-502.
15. Marsh S.G., Albert E.D., Bodmer W.F., Bontrop R.E., Dupont B., Erlich H.A., Geraghty D.E., Hansen J.A., Hurley C.K., Mach B. Nomenclature for factors of the HLA system, 2004. Hum Immunol 2005, 66(5):571-636.
16. Svejgaard A., Ryder L.P. HLA and disease associations: detecting the strongest association. Tissue Antigens 1994, 43(1):18-27.
17. Yoon J.H., Shin S., Park M.H., Song E.Y., Roh E.Y. HLA-A, -B, -DRB1 allele frequencies and haplotypic association from DNA typing data of 7096 Korean cord blood units. Tissue Antigens 2010, 75(2):170-173.
18. Roh E.Y., Kim H.S., Kim S.M., Lim Y.M., Han B.Y., Park M.H. HLA-A, -B, -DR allele frequencies and haplotypic associations in Koreans defined by eneric-level DNA typing. Korean J Lab Med 2003, 23:420-430.
19. Futagawa Y., Waki K., Cai J. The association of HLA-DR13 with lower graft survival rates in hepatitis B and primary sclerosing cholangitis Caucasian patients receiving a liver transplant. Liver Transpl 2006, 12(4):600-604.
20. Singh R., Kaul R., Kaul A., Khan K. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol 2007, 13(12):1770-1787.
21. Fletcher G.J., Samuel P., Christdas J., Gnanamony M., Ismail A.M., Anantharam R., Eapen C.E., Chacko M.P., Daniel D., Kannangai R. Association of HLA and TNF polymorphisms with the outcome of HBV infection in the South Indian population. Genes Immun 2011, 12(7):552-558.
22. Kim J.H., Koh D.K., Hur J.K., Kang J.H., Nainan O.V., Margolis H.S. The incidence rate of hepatitis B virus surface gene variants in Korean children with immunoprophylaxis failure of perinatal infection. Korean J Hepatol 2005, 11(4):320-328.
23. Ahn S.H., Han K.H., Park J.Y., Lee C.K., Kang S.W., Chon C.Y., Kim Y.S., Park K., Kim D.K., Moon Y.M. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology 2000, 31(6):1371-1373.
24. Cho S.W., Cheong J.Y., Ju Y.S., Oh do H., Suh Y.J., Lee K.W. Human leukocyte antigen class II association with spontaneous recovery from hepatitis B virus infection in Koreans: analysis at the haplotype level. J Korean Med Sci 2008, 23(5):838-844.
25. Lin H.H., Liao H.W., Lin S.K., Wang L.Y. HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination. Vaccine 2008, 26(27-28):3414-3420.
26. Wang C., Tang J., Song W., Lobashevsky E., Wilson C.M., Kaslow R.A. HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology 2004, 39(4):978-988.
27. Amirzargar A.A., Mohseni N., Shokrgozar M.A., Arjang Z., Ahmadi N., Yousefi Behzadi M., Amanzadeh A., Shokri F. HLA-DRB1, DQA1 and DQB1 alleles and haplotypes frequencies in Iranian healthy adult responders and non-responders to recombinant hepatitis B vaccine. Iran J Immunol 2008, 5(2):92-99.
28. Hennig B.J., Fielding K., Broxholme J., Diatta M., Mendy M., Moore C., Pollard A.J., Rayco-Solon P., Sirugo G., van der Sande M.A. Host genetic factors and vaccine-induced immunity to hepatitis B virus infection. PLoS One 2008, 3(3):e1898.
29. Mert G., Sengul A., Gul H.C., Karakas A., Eyigun C.P. The role of human leukocyte antigen tissue groups in hepatitis B virus vaccination in Turkey. J Microbiol Immunol Infect 2014, 47(1):9-14.
30. Caillat-Zucman S., Gimenez J.J., Wambergue F., Albouze G., Lebkiri B., Naret C., Moynot A., Jungers P., Bach J.F. Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen. Kidney Int 1998, 53(6):1626-1630.
31. Vidan-Jeras B., Brinovec V., Jurca B., Levicnik Steyinar S., Jeras M., Bohinjec M. The contribution of HLA-Class II antigens in humoral non-response and delayed response to HBsAG vaccination. Pflugers Arch 2000, 440(5 Suppl):R188-R189.
32. Xu Y.Y., Yu J.Y., Zhong Y.W., Song H.B., Liu H.H., Jia L.L., Li S.L., Xu J.Q., Li Q. Association between the frequency of class II HLA antigens and the susceptibility to intrauterine infection of hepatitis B virus. Int J Biol Sci 2008, 4(2):111-115.
33. Posteraro B., Pastorino R., Di Giannantonio P., Ianuale C., Amore R., Ricciardi W., Boccia S. The link between genetic variation and variability in vaccine responses: systematic review and meta-analyses. Vaccine 2014, 32(15):1661-1669.
34. Rahman F., Dahmen A., Herzog-Hauff S., Bocher W.O., Galle P.R., Lohr H.F. Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen. Hepatology 2000, 31(2):521-527.
35. Jafarzadeh A., Shokri F. TH1 and TH2 responses are influenced by HLA antigens in healthy neonates vaccinated with recombinant hepatitis B vaccine. Iran J Allergy Asthma Immunol 2012, 11(4):308-315.
36. Yucesoy B., Talzhanov Y., Johnson V.J., Wilson N.W., Biagini R.E., Wang W., Frye B., Weissman D.N., Germolec D.R., Luster M.I. Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations. Vaccine 2013, 31(46):5381-5391.
37. Jang M.K., Lee J.Y., Lee J.H., Kim Y.B., Kim H.Y., Lee M.S., Park C.K., Yoo J.Y. Seroepidemiology of HBV infection in South Korea, 1995 through 1999. Korean J Intern Med 2001, 16(3):153-159.